Caricamento...
Bendamustine for treatment of chronic lymphocytic leukemia
INTRODUCTION: Chronic lymphocytic leukemia (CLL) has an extended disease course in many patients. With a median age at diagnosis of 72 years, newer treatment options with less toxicity than standard nucleoside analogue-based regimens are needed. Historically, few therapy options are available once C...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2012
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3467097/ https://ncbi.nlm.nih.gov/pubmed/22663160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14656566.2012.693163 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|